veldoreotide [8632]



veldoreotide


SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCNC(=O)CCCN(CC(N)=O)C(=O)[C@H](Cc2ccccc2)NC1=O
InChIKey ABFNTRQPWNXUHA-VEVJRHMJSA-N
Sequence XFWWKTFG

Chemical Properties

Hydrogen bond acceptors 11
Hydrogen bond donors 12
Rotatable bonds 15
Log P 1.342
Molecular weight (Da) 1122.6
Stereochemistry info partial


No bioactivity data available.

veldoreotide


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.